These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9584189)

  • 1. No requirement for V(D)J recombination in p53-deficient thymic lymphoma.
    Liao MJ; Zhang XX; Hill R; Gao J; Qumsiyeh MB; Nichols W; Van Dyke T
    Mol Cell Biol; 1998 Jun; 18(6):3495-501. PubMed ID: 9584189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma.
    Liao MJ; Van Dyke T
    Genes Dev; 1999 May; 13(10):1246-50. PubMed ID: 10346813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice.
    Nacht M; Jacks T
    Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ
    Mol Cell Biol; 2002 May; 22(9):3174-7. PubMed ID: 11940674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
    Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
    Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK; Weaver Z; Barlow C; Shen R; Eckhaus M; Steinberg SM; Ried T; Wynshaw-Boris A; Hodes RJ
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6664-9. PubMed ID: 10841564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors.
    Guidos CJ; Williams CJ; Grandal I; Knowles G; Huang MT; Danska JS
    Genes Dev; 1996 Aug; 10(16):2038-54. PubMed ID: 8769647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.
    Williams CJ; Grandal I; Vesprini DJ; Wojtyra U; Danska JS; Guidos CJ
    Mol Cell Biol; 2001 Jan; 21(2):400-13. PubMed ID: 11134329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes.
    Bogue MA; Zhu C; Aguilar-Cordova E; Donehower LA; Roth DB
    Genes Dev; 1996 Mar; 10(5):553-65. PubMed ID: 8598286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial reconstitution of V(D)J rearrangement and lymphocyte development in RAG-deficient mice expressing inducible, tetracycline-regulated RAG transgenes.
    Shockett PE; Zhou S; Hong X; Schatz DG
    Mol Immunol; 2004 Jan; 40(11):813-29. PubMed ID: 14687938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM and p53 are essential in the cell-cycle containment of DNA breaks during V(D)J recombination in vivo.
    Dujka ME; Puebla-Osorio N; Tavana O; Sang M; Zhu C
    Oncogene; 2010 Feb; 29(7):957-65. PubMed ID: 19915617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
    Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
    Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
    Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
    J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
    Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
    Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM.
    Isoda T; Takagi M; Piao J; Nakagama S; Sato M; Masuda K; Ikawa T; Azuma M; Morio T; Kawamoto H; Mizutani S
    Blood; 2012 Jul; 120(4):789-99. PubMed ID: 22709691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis.
    Morrison C; Smith GC; Stingl L; Jackson SP; Wagner EF; Wang ZQ
    Nat Genet; 1997 Dec; 17(4):479-82. PubMed ID: 9398855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RAG2 C terminus suppresses genomic instability and lymphomagenesis.
    Deriano L; Chaumeil J; Coussens M; Multani A; Chou Y; Alekseyenko AV; Chang S; Skok JA; Roth DB
    Nature; 2011 Mar; 471(7336):119-23. PubMed ID: 21368836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent and p53-independent pathways for radiation-induced immature thymocyte differentiation.
    Candéias SM; Mancini SJ; Touvrey C; Borel E; Jouvin-Marche E; Marche PN
    Oncogene; 2004 Mar; 23(10):1922-9. PubMed ID: 14755249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.